— Know what they know.
Not Investment Advice

SBBP NASDAQ

Strongbridge Biopharma plc
1W: -2.9% 1M: -10.7% 3M: -32.7% 1Y: -7.4% 3Y: -58.1% 5Y: -60.2%
$2.00
Last traded 2021-10-05 — delisted
NASDAQ · Healthcare · Biotechnology

📊 Key Metrics

TTM
$35M
Revenue
+35.0% YoY
$-40M
Net Income
+23.9% YoY
$-34M
Free Cash Flow
+5.0% YoY
95.3%
Gross Margin
-130.1%
Op. Margin
-131.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-87.1%
ROA-41.3%
ROIC2755.8%

Valuation

P/E-2.5
P/B1.7
EV/EBITDA-4.8

Leverage

Debt/Equity0.41
Current Ratio3.00
Interest Cov.-14.0x

Quality Scores

Piotroski F4/9
Altman Z-2.81
Beneish M-2.64

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms